Ozempic In India
- All
- News
- Videos
- Web Stories
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
People Continue Taking Ozempic For Weight Loss Despite Side Effects, Reveals Study
The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic May Lower Risk Of Epilepsy In Diabetes Patients, New Study Finds
The study offers early evidence of neurological benefits from these diabetes and weight loss medications.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
People Continue Taking Ozempic For Weight Loss Despite Side Effects, Reveals Study
The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic May Lower Risk Of Epilepsy In Diabetes Patients, New Study Finds
The study offers early evidence of neurological benefits from these diabetes and weight loss medications.
